Synthetic and structural biology of Rab GTPase networks

This project aims to elucidate the self-organizing mechanisms of Rab GTPase networks using synthetic biology, cryo-electron microscopy, and microfabrication to enhance understanding of eukaryotic cell organization.

Subsidie
€ 1.928.624
2023

Projectdetails

Introduction

Eukaryotic cells are characterized by their compartmentalization into hundreds of different membrane-bound organelles with unique biochemical identities. Small GTPases of the Rab family play a central role in this organization, but how they are able to generate spatiotemporal order in the complex cellular environment is currently not known.

Current Understanding

Most previous studies on Rab GTPases have either relied on describing their behavior in living cells or in highly reductionist biochemical assays. However, neither of these two approaches can explain the dynamic activity patterns of Rab GTPases associated with their cellular functions.

Regulatory Networks

It has become clear that Rab GTPases are controlled in sophisticated regulatory networks with emergent, self-organizing properties. To obtain a mechanistic understanding of these Rab GTPase systems, new experimental assays are now required.

Proposed Methodology

In this proposal, we will use a “bottom-up” synthetic biology approach to rebuild the biochemical networks of Rab GTPases from purified components and demonstrate their self-organization into spatiotemporal activity patterns in vitro.

Experimental Techniques

We will combine these reconstitution experiments with cryo-electron microscopy to elucidate the structures of membrane-recruited Rab GTPase regulators. Finally, we will use microfabrication and laser lithography to prepare a mimic for the compartmentalized cell and find out how Rab GTPase signaling systems sense and process preexisting geometric and biochemical cues as in the living cell.

Expected Outcomes

This project will provide novel, quantitative information from different scales, from the emergent ensemble behavior down to the molecular structure of protein complexes. Together, this data will reveal how signaling systems of Rab GTPases control membrane identities in space and time, thereby improving our understanding of the intracellular organization of the eukaryotic cell.

Financiële details & Tijdlijn

Financiële details

Subsidiebedrag€ 1.928.624
Totale projectbegroting€ 1.928.624

Tijdlijn

Startdatum1-1-2023
Einddatum31-12-2027
Subsidiejaar2023

Partners & Locaties

Projectpartners

  • INSTITUTE OF SCIENCE AND TECHNOLOGY AUSTRIApenvoerder

Land(en)

Austria

Vergelijkbare projecten binnen European Research Council

ERC Starting...

Molecular mechanisms of GPCR heteromers signaling

This project aims to elucidate the molecular mechanisms of GPCR heteromer assembly and signaling, focusing on the mGlu2-5HT2A complex to advance drug development for schizophrenia.

€ 1.499.494
ERC Starting...

Engineered control of cellular circuits

Developing light-controlled proteins to study spatiotemporal dynamics of signaling in active neuron subpopulations during learning, aiming to inform therapies for brain disorders.

€ 1.494.669
ERC Advanced...

The geometrical and physical basis of cell-like functionality

The project aims to uncover mechanistic principles for building life-like systems from minimal components using theoretical modeling and in-silico evolution to explore protein patterns and membrane dynamics.

€ 2.498.813
ERC Consolid...

Unravelling the chemical-physical principles of life through minimal synthetic cellularity

The project aims to construct synthetic cells with life-like properties by exploring compartmentalization and communication in molecular reaction networks to understand life's fundamental principles.

€ 1.999.167
ERC Starting...

How do tetraspanin proteins organize, shape, and remodel biological membranes?

This project aims to uncover the mechanisms of cell membrane remodelling involving Tetraspanin proteins to enhance understanding of fertilization and develop treatments for infertility and viral infections.

€ 1.495.625